期刊文献+

海南黎族哮喘患者血浆PAF及PAF-AH活性的观察 被引量:3

Observation on the activity of plasma PAF and PAF-AH in Li Nationality asthma patients in Hainan Province
下载PDF
导出
摘要 目的探讨血小板活化因子(PAF)及乙酰水解酶(PAF-AH)等活性变化在黎族居民支气管哮喘发病机制中的意义。方法采用酶联免疫法等方法测定48例海南黎族支气管哮喘患者发作期和缓解期血浆PAF及PAF-AH的活性变化,同时观察总IgE和嗜酸细胞阳离子蛋白(ECP)水平。结果黎族哮喘发作期患者PAF、总IgE和ECP水平较正常组均明显增高,缓解期较发作期明显降低,均有显著意义(P<0.01),缓解期仍高于正常组,但无显著意义(P<0.05);发作期PAF-AH活性较正常组均明显降低,缓解组较发作组明显增高,均有显著意义(P<0.01),但缓解组仍低于正常组(P<0.05)。结论黎族哮喘患者急性发作期血浆PAF活性明显增高、PAF-AH活性明显降低,提示PAF和PAF-AH活性变化在黎族哮喘的发生机制中可能有一定作用,其临床意义有待于进一步研究。 Objective To investigate the significance of changes of plasma platelet - activating factor (PCF) and platelet - activating factor acetylhydrolase (PAF- AH) activity in Li nationality asthma patients. Methods ELISA and other methods were used to detect the activity of plasma platelet - activating factor acetylhydrolase, platelet - activating factor, serum total IgE and ECP in 48 Li nationality asthma patients. Results The levels of plasma PAF, serum total IgE and ECP at acute stage were significantly higher than that of the remission stage ( P 〈 0.01 ) and the levels of plasma PAF - AH was significantly lower than that of in remission stage ( P 〈 0.01 ). In remission stage, The levels of PAF - AH was lower than that of normal subjects ( P 〈 0.05). Conclusion The activity of PAF at acute stage was obviously chanced, while the activity of PAF - AH was markedly reduced, sugesting that the changes of activity of PAF and PAF - AH may ply certein role in the pathogenisis of asthma in LI Nationality and further study on its clinical significance is indicated.
出处 《中国热带医学》 CAS 2006年第8期1354-1355,共2页 China Tropical Medicine
基金 海南省卫生厅基金资助(2000-1) 海南省自然科学基金资助(30222)
关键词 黎族 哮喘 血小板活化因子 乙酰水解酶 Li nationality Asthma Platelet - activating factor Acetylhydrolase
  • 相关文献

参考文献11

  • 1支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2006
  • 2Izaki S,Yamamoto T,Goto Y.Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation[J].Br J Dermatol,1997,136(3):467.
  • 3阳世光,姚新生,袁国会.银杏叶提取物防治兔心肌缺血再灌注损伤实验研究[J].中国煤炭工业医学杂志,2002,5(5):510-511. 被引量:10
  • 4Prescott SM,Zimmerman GA and McIntyre TM.Platelet-activating factor[J].J Biol Chem,1990,265:17381~17384.
  • 5Shindo K; Koide K; Fukumura M.Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients[J].Eur Respir J,1998 May,11:5,1098 ~ 1104.
  • 6Kuitert LM; Angus RM; Barnes NC; et al.Effect of a novel potent platelet-activating factor antagonist,modipafant,in clinical asthma[J].Am J Respir Crit Care Med,1995 May,151:5,1331 ~ 135.
  • 7Stafforini DM,Prescott SM,Zimmerman GA,et al.Platelet-activating factor acetylhydrolase activity in human tissues and blood cells[J].Lipids,1991,26:979 ~ 985.
  • 8Yoshia H,Imaizumi T,Fujimoto K,et al.A mutation in plasma plateltactivating factor acetylhydrolase is a genetic risk factor for cerebeal hemorrhage but not for hypertension[J].Thromb Hacmost,1998,80:372 ~ 375.
  • 9Tsukioka K; Matsuzaki M; Nakamata M; et al Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAF-AH) activity in adults with bronchial asthma[J].J Investig Allergol Clin Immunol,1996 Jan,6:1,22~29.
  • 10Miwa M,miyake T,Yamanaka T,et al.Characterization of serum Platelet-activating factor acetylhydrolase[J].J Clin Invest,1988,82:1983 ~1991.

二级参考文献3

共引文献2014

同被引文献31

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部